Gilead Sciences, Inc. (NASDAQ:GILD) Shares Bought by Rehmann Capital Advisory Group

Rehmann Capital Advisory Group lifted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.6% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,626 shares of the biopharmaceutical company’s stock after purchasing an additional 333 shares during the quarter. Rehmann […]

Leave a Reply

Your email address will not be published.

Previous post GE Vernova (NYSE:GEV) Price Target Raised to $390.00
Next post The BMW M3 Electric Sedan Shapes Up to Be a Game-Changer